Inventor · disambiguated record
Luitgard Nagel-Steger
Also filed as: NAGEL-STEGER LUITGARD
6 granted patents·4 pending applications·6 citations·filing 2003–2018
71Inventor score
Top patents by PatentIndex Score
10 records- 0178US9464118B2Polymers containing multivalent amyloid-beta-binding D-peptides and their useFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2013·Granted Oct 11, 2016·5 cites·18 claims
- 0271US10167318B2D-enantiomeric peptides derived from D3 and use thereofFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2017·Granted Jan 1, 2019·1 cites·20 claims
- 0367US10889618B2D-enantiomeric peptides derived from D3 and use thereofFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2018·Granted Jan 12, 2021·0 cites·18 claims
- 0451US2015307552A1Novel d-enantiomeric peptides derived from d3 and use thereofFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2013·Application pending·0 cites
- 0544US10746747B2Method for quantitative characterization of substances with regard to their properties of binding to amyloid-β (Aβ) conformersFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2014·Granted Aug 18, 2020·0 cites·12 claims
- 0644US10088487B2Method for the quantitative characterization of amyloid and/or aggregating peptides and/or proteins in a sampleFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2014·Granted Oct 2, 2018·0 cites·19 claims
- 0741US2016376335A1Polymers containing multivalent amyloid-beta-binding d-peptides and their useFORSCHUNGSZENTRUM JUELICH GMBH·Filed 2016·Application pending·0 cites
- 0838US2013143822A1Agents for treating alzheimer's diseaseFUNKE SUSANNE AILEEN·Filed 2011·Application pending·0 cites
- 0932US2005239808A1Active substances for the treatment, diagnosis and prophylaxis of diseases in which abnormal protein structures occurSCHRADER THOMAS·Filed 2003·Application pending·0 cites
- 1020US8481494B2Compounds for the treatment of diseases related to protein misfoldingSCHRADER THOMAS·Filed 2010·Granted Jul 9, 2013·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Luitgard Nagel-Steger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →